|
Volumn 39, Issue 1014, 1997, Pages 109-110
|
Pramipexole and ropinirole for Parkinson's disease
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BROMOCRIPTINE;
BROMOCRIPTINE MESILATE;
CIMETIDINE;
CIPROFLOXACIN;
DOPAMINE RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
METOCLOPRAMIDE;
NEUROLEPTIC AGENT;
PERGOLIDE;
PERGOLIDE MESILATE;
PLACEBO;
PRAMIPEXOLE;
ROPINIROLE;
BRADYCARDIA;
CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG MECHANISM;
DYSKINESIA;
HALLUCINATION;
HUMAN;
NAUSEA;
ON OFF PHENOMENON;
ORTHOSTATIC HYPOTENSION;
PARKINSON DISEASE;
SHORT SURVEY;
SOMNOLENCE;
SYNCOPE;
ANTIPARKINSON AGENTS;
BENZOTHIAZOLES;
CLINICAL TRIALS;
DOPAMINE AGONISTS;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
HUMANS;
INDOLES;
PARKINSON DISEASE;
THIAZOLES;
|
EID: 0031437638
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (1)
|
References (8)
|